Direxion Daily S&P Biotech Bear 3X Shares (LABD) |
|
20.6 0.6 (3%)
|
09-29 16:00 |
|
Open: |
19.59 |
Pre. Close: |
20 |
|
High:
|
20.8058 |
Low:
|
19.29 |
|
Volume:
|
4,308,865 |
Market Cap:
|
0(M) |
|
|
|
Technical analysis |
as of: 2023-09-29 4:28:43 PM |
|
Short-term rate:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
|
Mid-term rate:
|
 |
| Target: |
Six months: 25.57 One year: 29.87 |
| Support: |
Support1: 17.77 Support2: 15.22 |
| Resistance: |
Resistance1: 21.89 Resistance2: 25.57 |
| Pivot: |
19  |
| Moving Average: |
MA(5): 20.51  MA(20): 18.3
MA(100): 15.1 MA(250): 17.17 |
| MACD: |
MACD(12,26): 1.1 Signal(9): 0.9 |
| Stochastic oscillator: |
%K(14,3): 71.4 %D(3): 74 |
| RSI: |
RSI(14): 65.7 |
| 52-week: |
High: 26.39 Low: 11.18 |
| Average Vol(K): |
3-Month: 3,908 (K) 10-Days: 3,759 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ LABD ] has closed below upper band by 25.7%. Bollinger Bands are 86.4% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 6 days. This is a sign that the current trend might continue. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
20.83 - 20.91 |
20.91 - 21 |
|
Low:
|
19.09 - 19.17 |
19.17 - 19.27 |
|
Close:
|
20.44 - 20.58 |
20.58 - 20.74 |
|
Company Description |
|
The fund, under normal circumstances, invests in swap agreements, futures contracts, short positions or other financial instruments that, in combination, provide inverse (opposite) or short leveraged exposure to the index equal to at least 80% of the fund's net assets (plus borrowing for investment purposes). The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified. |
Headline News |
Fri, 29 Sep 2023
Buy the Dip in Apple, or has the Trend Turned Rotten? - Investor's Business Daily
Tue, 26 Sep 2023
India: Apple Creating Opportunity For Investors In Up And Coming Manufacturing Powerhouse - Apple (NASDAQ - Benzinga
Thu, 21 Sep 2023
SOXS, SOXL ETFs price outlook as semiconductor stocks retreat - Kalkine Media
Fri, 15 Sep 2023
Analyst who nailed the 'summer swoon' says buy this now - TheStreet
Thu, 17 Aug 2023
Direxion Daily 20+ Year Treasury Bull 3X ETF (TMF) Attracts Billions - Bloomberg
Wed, 09 Aug 2023
Inverse ETFs Soar as Market Turns Sour - Yahoo Finance
|
Financial Analysis |
| Price to Book Value: |
Neutral |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Neutral |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Neutral |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Neutral |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Neutral |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: AMEX |
| Sector: |
| Industry: |
| Shares Out. |
0 (M) |
| Shares Float |
0 (M) |
|
% Held by Insiders
|
0 (%) |
|
% Held by Institutions
|
0 (%) |
|
Shares Short
|
0 (K) |
|
Shares Short P.Month
|
0 (K) |
Stock Financials |
|
EPS
|
0 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
0 |
|
Profit Margin (%)
|
0 |
|
Operating Margin (%)
|
0 |
|
Return on Assets (ttm)
|
0 |
|
Return on Equity (ttm)
|
0 |
|
Qtrly Rev. Growth
|
0 |
|
Gross Profit (p.s.)
|
0 |
|
Sales Per Share
|
0 |
|
EBITDA (p.s.)
|
0 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
0 (M) |
|
Levered Free Cash Flow
|
0 (M) |
Stock Valuations |
|
PE Ratio
|
0 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
0 |
|
Price to Sales
|
0 |
|
Price to Cash Flow
|
0 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
